Minerva Neurosciences Stock (NASDAQ: NERV) stock price, news, charts, stock research, profile.
You can purchase shares of Minerva Neurosciences (NASDAQ:NERV) through any online brokerage.
Other companies in Minerva Neurosciences’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Immuron (NASDAQ:IMRN), Acurx Pharmaceuticals (NASDAQ:ACXP), CARISMA Therapeutics (NASDAQ:CARM) and Imunon (NASDAQ:IMNN).
Minerva Neurosciences has a consensus price target of $5.00.
The stock price for Minerva Neurosciences (NASDAQ: NERV) is $2.0901 last updated December 23, 2024 at 4:09 PM EST.
There are no upcoming dividends for Minerva Neurosciences.
Minerva Neurosciences’s Q4 earnings are confirmed for Thursday, February 20, 2025.
There is no upcoming split for Minerva Neurosciences.
Minerva Neurosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.